![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
SABCS 2017: Immunotherapy Shows Early Promise for Patients With Trastuzumab-resistant Breast Cancer (Oncoletter) View |
![]() |
Immunotherapy shows early promise for patients with trastuzumab-resistant breast cancer (ecancer) View |
![]() |
SABCS 2017: Adjuvant Trastuzumab Did Not Improve Outcomes for Patients With HER2-low Breast Cancer (Oncoletter) View |
![]() |
PIII trial supports current standard 12-month adjuvant trastuzumab for HER2-positive breast cancer (ecancer) View |
![]() |
SABCS 2017 – Irene Wapnir, Part 2 (Touch Medical Media) View |
![]() |
The REACT trial: Celecoxib vs placebo for primary breast cancer (ecancer) View |
![]() |
Dra Alessandra Morelle - SABCS 2017 (Oncology Information Group) View |
![]() |
SABCS: Celebrating 40 Years of Progress Against Breast Cancer (American Association for Cancer Research) View |
![]() |
SABCS 2017: Acupuncture Reduced Joint Pain Caused by Aromatase Inhibitor Treatment (Oncoletter) View |
![]() |
Telazoparib vs physicians choice for patients with mBRCA1 breast cancern (ecancer) View |